Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Travere Therapeutics Inc (TVTX)

259 + Investors. Track Smart Money conviction in TVTX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -19
Streak
1Q ▼
Buyers last Q
47%

Smart Money Signals — TVTX

Based on 260 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their TVTX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 93% of 3.0Y peak

93% of all-time peak
260 funds currently hold this stock — 93% of the 3.0-year high of 279 funds (reached 2025 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +18% more funds vs a year ago

fund count last 6Q
+40 new funds entered over the past year (+18% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟠

More sellers than buyers — 47% buying

144 buying163 selling
Last quarter: 163 funds reduced or exited vs 144 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
⚠️

Fewer new buyers each quarter (-28 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 40 → 57 → 76 → 48. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

49% of holders stayed for 2+ years

■ 49% conviction (2yr+) ■ 23% medium ■ 28% new
128 out of 260 hedge funds have held TVTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -0%, value -23%

Value
-23%
Shares
0%
Last quarter: funds added -0% more shares while total portfolio value only changed -23%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

49 → 40 → 57 → 76 → 48 new funds/Q
New funds entering each quarter: 40 → 57 → 76 → 48. A growing number of institutions are discovering TVTX each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 58% veterans vs 30% newcomers

■ 58% veterans ■ 12% 1-2yr ■ 30% new
Entry-cohort mix of 276 holders: 160 (58%) are 2+ year veterans, 32 entered 1–2 years ago, and 84 (30%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 43% AUM from top-100 funds

43% from top-100 AUM funds
47 of 257 holders are among the 100 largest funds by AUM, controlling 43% of total institutional value in TVTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.9
out of 10
Low Exit Risk
Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TVTX

In 2026 Q1, 144 hedge funds were net buyers of TVTX (48 opened a new position, 96 added to an existing one), while 163 reduced or exited (96 trimmed, 67 sold completely) — a 47% buyer ratio, indicating roughly balanced activity. 43% of total institutional value in TVTX is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -19 funds (more exits than new entries). Total institutional holders: 260.

Hedge Fund Ownership: TVTX

How many hedge funds hold TVTX — quarterly history vs. share price
Quarterly hedge fund ownership of TVTX vs. share price

Market Analysis: TVTX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TVTX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Travere Therapeutics Inc (TVTX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much TVTX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 78d ago
TVTX
+82.5%
XLV
+4.0%

TVTX outperformed XLV by +78.5% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 33d ago
TVTX
+27.3%
XLV
+5.1%

Since the filing became public, TVTX outperformed XLV by +22.2% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

26 top-rated funds 4 high-conviction
Consensus
6.2
/ 10
breadth
×
Elite
3.0
/ 10
conviction
Hedge Fund Positioning: TVTX
259 + Investors

Track Smart Money conviction in TVTX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 259 279 -7.17%
13F Shares 106M 107M -0.49%
Total Value $3.12B $4.06B -23.2%
New Positions 47 76 -29
Increased Positions 94 92 +2
Closed Positions 67 37 +30
Reduced Positions 90 96 -6
Total Calls 7 10 -30.0%
Total Puts 12 13 -7.69%
PUT/CALL Ratio 1.71 1.3 Bearish

Statistics: TVTX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

259 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TVTX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 TVTX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Ishara Investments LP 3.11% 110,700 $3.3M
2 Palisades Investment Partners, LLC 2.97% 255,240 $7.6M
3 Kynam Capital Management, LP 2.88% 1,569,018 $46.6M
4 MPM BioImpact LLC 2.60% 1,133,365 $33.7M
5 Rock Springs Capital Management LP 2.59% 1,477,954 $43.9M
6 Armistice Capital, LLC 2.59% 4,897,417 $145.5M
7 Knott David M Jr 2.49% 140,633 $4.2M
8 Perceptive Advisors LLC 2.41% 4,142,551 $123.1M
9 Superstring Capital Management LP 2.18% 102,754 $3.1M
10 KVP Capital Advisors, LP 2.02% 91,000 $2.7M
11 Elmind Capital, LP 1.50% 177,600 $5.3M
12 Kynam Capital Management, LP 1.47% 800,000 $23.8M
13 Emerald Advisers, LLC 1.46% 1,557,196 $46.3M
14 Emerald Mutual Fund Advisers Trust 1.36% 945,033 $28.1M
15 Palo Alto Investors LP 1.05% 230,453 $6.8M
16 Eversept Partners, LP 0.85% 542,610 $16.1M
17 Essex Investment Management Co LLC 0.76% 161,705 $4.8M
18 Stephens Investment Management Group LLC 0.73% 1,798,466 $53.4M
19 Soleus Capital Management, L.P. 0.66% 546,000 $16.2M
20 Kingdon Capital Management, L.L.C. 0.65% 200,000 $5.9M
21 Birchview Capital, LP 0.49% 29,200 $868K
22 Affinity Asset Advisors, LLC 0.46% 300,000 $8.9M
23 Artia Global Partners LP 0.42% 70,700 $2.1M
24 Lisanti Capital Growth, LLC 0.36% 48,185 $1.4M
25 F/m Investments LLC 0.33% 164,990 $4.9M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Travere Therapeutics Inc (TVTX)

What does the Smart Money Trend signal show for TVTX?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their TVTX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for TVTX?

More sellers than buyers — 47% buying: Last quarter: 163 funds reduced or exited vs 144 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for TVTX holders?

Elite ownership — 43% AUM from top-100 funds: 47 of 257 holders are among the 100 largest funds by AUM, controlling 43% of total institutional value in TVTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held TVTX?

49% of holders stayed for 2+ years: 128 out of 260 hedge funds have held TVTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Travere Therapeutics Inc (TVTX) following the 2026 Q1 hedge fund 13F filings?

As of today, TVTX has moved +27.3% since the 2026 Q1 13F filing date (May 15, 2026), compared to +5.1% for the XLV sector ETF — an outperformance of +22.2%. Since the quarter end (March 31, 2026), TVTX has gained +82.5% vs +4.0% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →